Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CHLORPROMAZINE Cause Therapy partial responder? 16 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Therapy partial responder have been filed in association with CHLORPROMAZINE (Chlorpromazine). This represents 0.4% of all adverse event reports for CHLORPROMAZINE.

16
Reports of Therapy partial responder with CHLORPROMAZINE
0.4%
of all CHLORPROMAZINE reports
1
Deaths
12
Hospitalizations

How Dangerous Is Therapy partial responder From CHLORPROMAZINE?

Of the 16 reports, 1 (6.3%) resulted in death, 12 (75.0%) required hospitalization.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CHLORPROMAZINE. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does CHLORPROMAZINE Cause?

Drug ineffective (374) Toxicity to various agents (301) Off label use (288) Drug abuse (243) Overdose (223) Foetal exposure during pregnancy (190) Neuroleptic malignant syndrome (186) Somnolence (170) Neutropenia (169) Seizure (164)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which CHLORPROMAZINE Alternatives Have Lower Therapy partial responder Risk?

CHLORPROMAZINE vs CHLORPROTHIXENE CHLORPROMAZINE vs CHLORTHALIDONE CHLORPROMAZINE vs CHLORZOXAZONE CHLORPROMAZINE vs CHOLECALCIFEROL CHLORPROMAZINE vs CHOLECALCIFEROL\ERGOCALCIFEROL

Related Pages

CHLORPROMAZINE Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder CHLORPROMAZINE Demographics